Lynch Syndrome (Hereditary Nonpolyposis Colon Cancer): A Case Study of Ethical Implications



Lynch Syndrome (Hereditary Nonpolyposis Colon Cancer): A Case Study of Ethical Implications


Deborah J. MacDonald PhD, RN, APNG



Most cancer occurs as a result of acquired genetic changes in a specific cell type. However, 5%-10% of some cancers occur because of a germline mutation (abnormality) in a single gene. These mutations are passed on to subsequent generations via the egg or sperm, generally in an autosomal dominant manner. In autosomal dominant inheritance, each child of a carrier of a cancer-associated gene mutation has a 50% (1:2) chance of inheriting the mutation. Individuals who inherit a cancer-associated gene mutation are at high risk for early-onset cancers, when screening or risk-reducing strategies are typically not in place. Genetic testing to identify these individuals is increasingly being incorporated into clinical practice and is now standard medical management for some heritable malignancies (American Society of Clinical Oncology 2003; Weitzel 2003). Although the technology enables implementing strategies to reduce cancer risk and help find cancer at an earlier stage, genetic testing for cancer predisposition has complex ethical, legal, and social implications (ELSI) not only for the person undergoing testing but also their family.


The International Society of Nurses in Genetics (ISONG) and the Oncology Nursing Society (ONS) have published position statements about the role of the nurse in genetic risk assessment, counseling, and testing (ISONG 2000, 2001, 2002, 2003; Oncology Nursing Society 2000a, 2000b). Counseling based on cancer predisposition testing must be more directive than traditional non-directive genetic counseling because persons desiring test results expect to be given recommendations for prevention or early detection of cancer. Nurses knowledgeable about the ELSI issues in hereditary cancer can provide anticipatory guidance, education, advocacy, psychological support, and appropriate referrals for individuals and their families (ANA 2007; MacDonald 1997; Dimond, Calzone, Davis, and Jenkins 1998; Lea, Jenkins and Francomano 1998; Tranin, Masny and Jenkins 2003; Lashley 1998; Loescher 1999; Flach and Jennings-Dozier 2000).

The following case composite depicts some ELSI issues confronted in the course of genetic cancer risk assessment (GCRA) for a family with Lynch syndrome. All names have been changed to maintain patient confidentiality, and details have been altered to protect anonymity while maintaining an accurate portrayal of ethical dilemmas. The case is presented from the viewpoint of the nurse on the cancer genetics team. The role of the nurse in facilitating positive outcomes for a family faced with ELSI issues is discussed.


Lynch Syndrome Case (Hereditary Nonpolyposis Colon Cancer)

Jane is a 47-year-old woman who had a colonoscopy at age 44 for evaluation of rectal bleeding, anemia, and unexplained weight loss. She was found to have an adenocarcinoma of the transverse colon with lymph node involvement, for which she had a segmental resection and chemotherapy. Her oncologist referred her for GCRA because her mother, brother, and maternal grandmother had also been diagnosed with colon cancer.


Cancer Risks in Lynch Syndrome

In Lynch syndrome, colon cancer typically occurs in the mid-40s, with few polyps, and a predominance of right-sided colon cancer. Colonoscopy (vs. sigmoidoscopy) is the appropriate screening tool. The distinguishing features of Lynch syndrome are early onset cancers as well as multiple primary tumors in affected individuals. This syndrome is most often caused by an abnormality in one of several mismatch DNA repair pathway genes (most often MLH1 or MSH2; occasionally MSH6, or more rarely, PMS2).


The risk for colon cancer in Lynch syndrome is about 80%. Women who have a mutation in one of the syndrome’s associated genes also have about a 35%-40% risk of endometrial cancer and up to a 10% risk of ovarian cancer. Persons with this syndrome also have a very high risk (>50%) for additional primary colorectal cancers and a small risk for upper GI cancers, transitional cell carcinomas of the renal pelvis, and cancers of the pancreato-biliary tract. The strictest diagnosis of Lynch syndrome is based on the “Amsterdam 3-2-1” criteria of having three affected family members with colon cancer, at least two generations affected, one case diagnosed before age 50, and one affected being a first-degree relative of the other two. Each child or sibling of a person with a mutation in one of the Lynch syndrome genes has a 50% (1:2) chance of inheriting the mutation.


Family History

Figure 27-1 depicts the family history in the form of a pedigree. Jane and her husband have a 16-year-old daughter, Kim, and two sons, John, age 23 and Steven, age 20. Jane has a 43-year-old sister, Anne, who does not have children. Jane and Anne’s only brother, Tom, died of colon cancer nearly six years ago, shortly after being diagnosed with the disease at age 45. Tom has a 31-year-old son, Scott, who does not have children. Jane’s 77-year old mother was treated for colon cancer in her cecum at age 65. The mother also had a hysterectomy and removal of both ovaries at age 50 for uterine fibroids, as did Jane’s only maternal female cousin, Linda, at age 45. Linda does not have children, neither does her 44-year-old brother, but their 49-year-old brother has two daughters, ages 18 and 20. Linda’s mother, age 75, had uterine cancer at age 49. Jane’s other maternal aunt died at age 29 in an automobile accident. The only maternal uncle, age 74, has not had cancer. The maternal grandmother had stomach cancer at age 55 and died of disease at age 56. She had one sibling, a brother who died at age 78 of heart disease. The maternal grandfather died at age 28 of leukemia. Jane had no further knowledge of his side of the family. There are no cancers in the paternal lineage other than a lung cancer at age 85 in the paternal grandfather.


Genetic Cancer Risk Assessment (GCRA)

At each counseling session the family was offered the support of the cancer center’s social worker and psychologist. Jane presented to clinic with her husband, expressing that her major motivation for the genetic consultation was to learn about her daughter’s risk for colon cancer. Jane states that she is not concerned about her sons having colon cancer, because they resemble her husband’s side of the family physically and in their personalities, in contrast to her daughter who is the “spitting image
of me.” Jane also believes that her cousin Linda is not at risk for colon cancer since Linda’s mother, Jane’s maternal aunt, has not had the disease.

Jane and her husband received extensive counseling from the GCRA multidisciplinary team regarding Lynch syndrome and its implications for Jane’s health care as well as for their children and other relatives. The couple decided that trying to identify the cause of the colon cancers was something they wanted to pursue. After discussing this with their family, they returned to the clinic anxious to proceed with genetic testing.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 26, 2016 | Posted by in GENERAL SURGERY | Comments Off on Lynch Syndrome (Hereditary Nonpolyposis Colon Cancer): A Case Study of Ethical Implications

Full access? Get Clinical Tree

Get Clinical Tree app for offline access